Blood Cancer United CEO salary and executive pay
Leukemia & Lymphoma Society paid its CEO, E Anders Kolb, $930,517 for the fiscal year ending June 2025. On the return for the fiscal year ending June 2024, the CEO was E Anders Kolb - Start 512023, paid $479,839. Total revenue on that return was $358,698,504, down 2.6% from $368,242,059 for the fiscal year ending June 2024. Leukemia & Lymphoma Society ranks 11th of 11 disease charities and medical research groups on this site by CEO pay. Leukemia & Lymphoma Society has 4 Form 990 returns on record, for fiscal years ending 2022 to 2025. Also known as Leukemia & Lymphoma Society.
Last updated from IRS e-file data. EIN 13-5644916, Washington, DC.
CEO, fiscal year ending June 2025
$930,517
- Total revenue
- $358,698,504
- CEO pay vs. peers
- Higher than 26%
Source: Form 990, fiscal year ending June 2025, IRS object ID 202620589349300007.View the filing
Peers: the 207 other organizations on this site with revenue of $50 million to $500 million. Ranked 153rd of 208 by top pay as a share of revenue. Pay is 0.26% of revenue, our calculation from the same return. Revenue is Part I, line 12; peers are compared on their latest full-year returns.
Highest-paid people on the latest return
On the latest return, 5 people were paid more than $500,000, none of them more than $1 million.
| Name and title | Total |
|---|---|
| E Anders Kolb CEO PRESIDENT & CEO | $930,517 |
| Gwen NicholsEVP, CHIEF MED OFFICER | $781,735 |
| Gordon MillerEVP, CHIEF FIN OFFICER | $704,797 |
| Flora Coker PowellEVP, CHIEF REV OFFICER | $572,147 |
| Dale NissenbaumFORMER EVP, GEN CNSL - END 05/2024 | $563,566 |
Also paid on the latest return: Lee Greenberger (SVP, CHIEF SCI OFFICER - END 12/2024), $453,722; Susan Brown (SVP, CHIEF SUS OFF END - 11/12/2024), $449,075; Florence Godfrey (SVP, CHIEF EXPERIENCE OFFICER), $447,138; Elisa Weiss (SVP, EDUCATION), $413,122; Andrew Perry (SVP, BUS OPS AND TECHNOLOGY), $407,035; Meredith Fogel (EVP, GEN COUNSEL - START 09/2024), $367,271; Troy Dunmire (FORMER EVP, CF OP OFF - END 01/2024), $271,634; Shonette Harrison Carew (EVP, CHIEF ADMIN OFF - START 09/2024), $162,632; Orlando Ashworth (EVP, CHIEF PEOPLE - START 10/2024), $95,602.
Also listed in Part VII of the latest return, with no pay reported: Alessandra Tocco (CHAIR), Freda Wang (VICE CHAIR), Marla Persky (SECRETARY/TREASURER), Janice Gabrilove MD (AT LARGE), Leroy Ball (BOD MEMBER), Richard Bagger (BOD MEMBER), Mark Barrenechea (BOD MEMBER), Renzo Canetta (BOD MEMBER), M Casey Cunningham (BOD MEMBER), Sharon Castellino (BOD MEMBER), Mike Farmer (BOD MEMBER), Ari Melnick (BOD MEMBER), Kathleen Meriwether (BOD MEMBER), Ruben Mesa (BOD MEMBER), Lynne O'Brien (BOD MEMBER), Alex Okafor (BOD MEMBER), Jim Reddoch (BOD MEMBER), Richard Rendina (BOD MEMBER), Robert Rosen (BOD MEMBER), Rayne H Rouce MD (BOD MEMBER), Jeff Sachs (BOD MEMBER), Lilian Stern (BOD MEMBER), Yvette Tremonti (BOD MEMBER).
CEO pay by year
Each row is the CEO on that year's return.
| Fiscal year ending | Name and title | Total | Revenue | Source |
|---|---|---|---|---|
| Jun 2025 | E Anders Kolb CEO PRESIDENT & CEO | $930,517 | $358,698,504 | Filing |
| Jun 2024 | E Anders Kolb - Start 512023 CEO PRESIDENT & CEO | $479,839 | $368,242,059 | Filing |
| Jun 2023 | Louis Jdegennaro-End 63023 CEO PRESIDENT & CEO | $931,409 | $378,338,490 | Filing |
| Jun 2022 | Louis J Degennaro CEO PRESIDENT & | $1,062,390 | $426,997,204 | Filing |
How this pay was reported
The parts of each total, as reported on the return for the fiscal year ending June 2025.
Source: Form 990, fiscal year ending June 2025, IRS object ID 202620589349300007.View the filing
| Part VII | Schedule J | |||||||
|---|---|---|---|---|---|---|---|---|
| Name and title | From org | Other | Base | Bonus | Other | Deferred | Nontaxable | Total |
| E Anders KolbPRESIDENT & CEO | $879,998 | $50,519 | $678,834 | $200,000 | $1,164 | $4,982 | $45,537 | $930,517 |
| Gwen NicholsEVP, CHIEF MED OFFICER | $736,394 | $45,341 | $466,269 | $105,142 | $164,983 | $17,250 | $28,091 | $781,735 |
| Gordon MillerEVP, CHIEF FIN OFFICER | $648,480 | $56,317 | $404,089 | $90,964 | $153,427 | $17,250 | $39,067 | $704,797 |
| Flora Coker PowellEVP, CHIEF REV OFFICER | $512,813 | $59,334 | $433,238 | $57,711 | $21,864 | $17,250 | $42,084 | $572,147 |
| Dale NissenbaumFORMER EVP, GEN CNSL - END 05/2024 | $547,759 | $15,807 | $397,356 | $0 | $150,403 | $5,933 | $9,874 | $563,566 |
These figures come from Leukemia & Lymphoma Society's Form 990 returns, as the IRS publishes them. The methodology page explains how they're chosen. To report an error, email corrections@ceopaycheck.com.
How Leukemia & Lymphoma Society compares
Ranked 11th of 11 disease charities and medical research groups by CEO pay.
- Previous in this ranking: 10th, Broad Institute, $982,376
Closest in revenue among organizations in the same revenue band:
San Francisco Foundation$670,879 (CEO), fiscal year ending Jun 2025
United States Pharmacopeia$1,104,534 (CEO), fiscal year ending Jun 2025
Cystic Fibrosis Foundation$1,275,151 (CEO), fiscal year ending Dec 2024
National Academy of Sciences$1,188,162 (CEO), fiscal year ending Dec 2024- Catholic Charities Diocese of Fort Worth$292,348 (CEO), fiscal year ending Dec 2024
Common questions
E Anders Kolb (PRESIDENT & CEO) was paid $930,517 for the fiscal year ending June 2025: $879,998 from Leukemia & Lymphoma Society and $50,519 in other compensation (Part VII columns D and F).
The CEO, E Anders Kolb, was the highest-paid person on the latest return, at $930,517.
Leukemia & Lymphoma Society paid its CEO, E Anders Kolb, $930,517 for the fiscal year ending June 2025. On the return for the fiscal year ending June 2024, the CEO was E Anders Kolb - Start 512023, paid $479,839. The earliest return on record is for the fiscal year ending June 2022, when the CEO was Louis J Degennaro, paid $1,062,390. By fiscal year end: June 2022, $1,062,390 (Louis J Degennaro); June 2023, $931,409 (Louis Jdegennaro-End 63023); June 2024, $479,839 (E Anders Kolb - Start 512023); June 2025, $930,517 (E Anders Kolb).
Leukemia & Lymphoma Society's return for the fiscal year ending June 2025 reports total expenses of $398,128,476 and total revenue of $358,698,504 (Part I, lines 18 and 12), so expenses exceeded revenue by $39,429,972. Expenses were $371,792,172 for the fiscal year ending June 2024, so they rose 7.1%. The CEO's pay of $930,517 equals 0.23% of expenses, our calculation.
From the 4 Form 990 returns Blood Cancer United filed with the IRS for fiscal years ending 2022 to 2025. The latest full-year return was filed on February 27, 2026. Schedule J of the fiscal year ending June 2025 return breaks down pay for all 5 people in the pay breakdown above.